Breast cancer cases of female patients under 35 years of age in Togo: A series of 158 cases

Darré,Tchin; Tchaou,Mazamaesso; Folligan,Koué; Amadou,Abdoulatif; N'Timon,Bidamin; Sonhaye,Lantam; Aboubakari,Abdoul‑Samadou; Amégbor,Koffi; Akpadza,Koffi; Napo Koura,Gado

doi:10.3892/mco.2017.1461

Breast cancer cases of female patients under 35 years of age in Togo: A series of 158 cases

Authors:
- Tchin Darré
- Mazamaesso Tchaou
- Koué Folligan
- Abdoulatif Amadou
- Bidamin N'Timon
- Lantam Sonhaye
- Abdoul‑Samadou Aboubakari
- Koffi Amégbor
- Koffi Akpadza
- Gado Napo Koura
View Affiliations

Affiliations: Department of Pathology, The University Teaching Hospital of Lomé, Lomé BP1515, Togo, Department of Imaging, The University Teaching Hospital of Lomé, Lomé BP1515, Togo, Department of Histology‑Embryology, The University Teaching Hospital of Lomé, Lomé BP1515, Togo, Department of Obstetrics and Gynecology, University Teaching Hospital of Lomé and Kara, Kara BP18, Togo
Published online on: October 18, 2017 https://doi.org/10.3892/mco.2017.1461
Pages: 1125-1129

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Breast cancer in young female patients represents a public health problem in developing countries. The objectives of the study were to study the epidemiological and histological characteristics of breast cancer in female patients under 35 years of age. This was a retrospective analytical study of a series of 158 cases of breast cancer in female patients under 35 years of age, conducted at the University Teaching Hospital of Lomé between 2000 and 2015. A total of 158 cases were collected, representing 36.2% (436) of all breast cancer cases. The average age of the patients was 30.9 years (range, 16‑35 years). A family history of breast cancer at the 1st or 2nd degree was identified in 13.9% of cases. Genetic mutation studies were carried out for 7 patients, 5 of which revealed mutations (4 BRCA1 and 1 BRCA2). According to the locus, the cancer was located preferentially in the left breast in 88 cases (55.7%). Malignant mammary lesions were epithelial tumors (n=144 cases, 91.1%), infiltrating (n=125 cases, 79.1%) and non‑infiltrating (n=19 cases, 12.0%). The other histological groups consisted of 8 cases of sarcomas (5 cases of angiosarcoma, 2 cases of fibrosarcoma and 1 case of Kaposi's sarcoma), 5 cases of lymphomas and one case of melanoma. Not otherwise specified infiltrating ductal carcinomas were SBR II and III in 43.2 and 35.2% of cases, respectively. The tumors classified as T4 were the most frequent (30.4%). Regarding the lymph node status, lymph node metastasis was noted in 22.8% of cases. Studies of hormone receptors were carried out in 23 patients and were positive for 11 patients: Estrogen receptor (ER)+plus progesterone receptor (PR)+(7 patients), ER+PR‑(4 patients). Of the aforementioned 8 cases of sarcoma, 5 were angiosarcoma. The lymphomas were predominantly Burkitt's type for 4 cases. Mammary ultrasonography was performed in 45.6% of the patients and 54.4% underwent the combined ultrasonography and mammography. Ultrasound identified one or more sign of malignancy in 67 patients (42.4%), and combined ultrasonography and mammography classified 51.9% of lesions in BIRADS 4 and 5. The incidence of breast cancer in young Togolese patients is high. It is a disease distinguished by a delay in diagnosis, which contributes to the high number of cases that initially diagnosed at an advanced stage, particularly the high histo‑prognosis grades of infiltrating ductal carcinoma. These results indicate a genetic origin; therefore, a thorough investigation into genetic mutations should be carried. In addition, further collaborative studies are required to verify these results.

View Figures

View References

1	Pollán M: Epidemiology of breast cancer in young women. Breast Cancer Res Treat. 123 Suppl 1:S3–S6. 2010. View Article : Google Scholar
2	Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and Bray F: Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403. 2013. View Article : Google Scholar : PubMed/NCBI
3	Anderson WF, Chatterjee N, Ershler WB and Brawley OW: Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology and end results database. Breast Cancer Res Treat. 76:27–36. 2002. View Article : Google Scholar : PubMed/NCBI
4	Eng C, Schneider K, Fraumeni JF Jr and Li FP: Third international workshop on collaborative interdisciplinary studies of p53 and other predisposing genes in Li-Fraumeni syndrome. Cancer Epidemiol Biomarkers Prev. 6:379–383. 1997.PubMed/NCBI
5	Partridge AH, Pagani O, Abulkhair O, Aebi S, Amant F, Azim HA Jr, Costa A, Delaloge S, Freilich G, Gentilini OD, et al: First international consensus guidelines for breast cancer in young women (BCY1). Breast. 23:209–220. 2014. View Article : Google Scholar : PubMed/NCBI
6	Lacombe J, Mangé A, Bougnoux AC, Prassas I and Solassol J: A multiparametric serum marker panel as a complementary test to mammography for the diagnosis of node-negative early-stage breast cancer and DCIS in young women. Cancer Epidemiol Biomarkers Prev. 23:1834–1842. 2014. View Article : Google Scholar : PubMed/NCBI
7	Perry NM, Patani N, Milner SE, Pinker K, Mokbel K, Allgood PC and Duffy SW: The impact of digital mammography on screening a young cohort of women for breast cancer in an urban specialist breast unit. Eur Radiol. 21:676–682. 2011. View Article : Google Scholar : PubMed/NCBI
8	Fregene A and Newman LA: Breast cancer in sub-Saharan Africa: How does it relate to breast cancer in African-American women? Cancer. 103:1540–1550. 2005. View Article : Google Scholar : PubMed/NCBI
9	Greenlee RT, Murray T, Bolden S and Wingo PA: Cancer statistics, 2000. CA Cancer J Clin. 50:7–33. 2000. View Article : Google Scholar : PubMed/NCBI
10	Le Guyader-Peyrou S, Belot A, Maynadié M, Binder-Foucard F, Remontet L, Troussard X, Bossard N and Monnereau A: French network of cancer registries (Francim): Cancer incidence in France over the 1980–2012 period: Hematological malignancies. Epidemiol Sante Publique. 64:103–112. 2016. View Article : Google Scholar
11	Gueye M, Gueye Kane SM, Gueye Ndiaye MD, Dia Niasse F, Gassama O, Diallo M and Moreau JC: Breast cancer in women younger than 35 years: Features and outcomes in the breast unit at aristide le dantec teaching hospital, dakar. Med Sante Trop. 26:377–381. 2016.PubMed/NCBI
12	Assi HA, Khoury KE, Dbouk H, Khalil LE, Mouhieddine TH and El Saghir NS: Epidemiology and prognosis of breast cancer in young women. J Thorac Dis. 1 5 Suppl:S2–S8. 2013.
13	Henderson TO, Amsterdam A, Bhatia S, Hudson MM, Meadows AT, Neglia JP, Diller LR, Constine LS, Smith RA, Mahoney MC, et al: Systematic review: Surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med. 152:444–455. 2010. View Article : Google Scholar : PubMed/NCBI
14	Meynard G, Mansi L, Lebahar P, Villanueva C, Klajer E, Calcagno F, Vivalta A, Chaix M, Collonge-Rame MA, Populaire C, et al: First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report. Oncol Rep. 37:1573–1578. 2017. View Article : Google Scholar : PubMed/NCBI
15	Anderson WF, Rosenberg PS, Menashe I, Mitani A and Pfeiffer RM: Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst. 100:1804–1814. 2008. View Article : Google Scholar : PubMed/NCBI
16	Bollet MA, Sigal-Zafrani B, Mazeau V, Savignoni A, de la Rochefordière A, Vincent-Salomon A, Salmon R, Campana F, Kirova YM, Dendale R and Fourquet A: Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first. Radiother Oncol. 82:272–280. 2007. View Article : Google Scholar : PubMed/NCBI
17	Chan A, Pintilie M, Vallis K, Girourd C and Goss P: Breast cancer in women < or=35 years: Review of 1002 cases from a single institution. Ann Oncol. 11:1255–1262. 2000. View Article : Google Scholar : PubMed/NCBI
18	Lammers EJ, Huibers P, van der Sangen MJ, van de Poll-Franse LV, Poortmans PM, Ernst MF, Lemaire BM, Meijs CM, Nuytinck HK and Voogd AC: Factors contributing to improved local control after mastectomy in patients with breast cancer aged 40 years or younger. Breast. 19:44–49. 2010. View Article : Google Scholar : PubMed/NCBI
19	Gentilini O, Botteri E, Rotmensz N, Toesca A, De Oliveira H, Sangalli C, Colleoni M, Intra M, Galimberti V, Veronesi P, et al: Breast-conserving surgery in 201 very young patients (<35 years). Breast. 19:55–58. 2010. View Article : Google Scholar : PubMed/NCBI
20	Gonzalez-Angulo AM, Broglio K, Kau SW, Eralp Y, Erlichman J, Valero V, Theriault R, Booser D, Buzdar AU, Hortobagyi GN and Arun B: Women age < or=35 years with primary breast carcinoma: Disease features at presentation. Cancer. 103:2466–2472. 2005. View Article : Google Scholar : PubMed/NCBI
21	Effi AB, Aman NA, Koui BS, Koffi KD, Traoré ZC and Kouyate M: Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: Relationship with clinicopathologic factors in 302 patients in ivory coast. BMC Cancer. 17:1152017. View Article : Google Scholar : PubMed/NCBI
22	Albrektsen G, Heuch I and Thoresen SØ: Histological type and grade of breast cancer tumors by parity, age at birth and time since birth: A register-based study in Norway. BMC Cancer. 10:2262010. View Article : Google Scholar : PubMed/NCBI
23	Navarrete E, Janser JC, Pusel J, Rodier JF and Rodier D: Sarcoma of the breast. J Chir (Paris). 125:501–509. 1988.(In French). PubMed/NCBI
24	Prévot S, Hugol D, Le Tourneau A, Audouin J and Diebold J: Primary non-Hodgkin's malignant lymphoma of the breast. Anatomopathologic diagnosis of 14 cases. Bull Cancer. 77:123–136. 1990.PubMed/NCBI
25	Narayan AK, Visvanathan K and Harvey SC: Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: A retrospective cohort study. Breast Cancer Res Treat. 158:583–589. 2016. View Article : Google Scholar : PubMed/NCBI
26	Lee SY, Jeong SH, Kim YN, Kim J, Kang DR, Kim HC and Nam CM: Cost-effective mammography screening in Korea: High incidence of breast cancer in young women. Cancer Sci. 100:1105–1111. 2009. View Article : Google Scholar : PubMed/NCBI
27	Chérel P, Hagay C, Benaim B, De Maulmont C, Engerand S, Langer A and Talma V: Mammographic evaluation of dense breasts: Techniques and limits. J Radiol. 89:1156–1168. 2008. View Article : Google Scholar : PubMed/NCBI